GLORIA
  • 2020 Jul 22
  • Global Research & Industry Alliance of the Ministry of ScienceTechnology shines in Bio Asia-Taiwan

The 2020 Bio Asia-Taiwan Exhibition will officially start on July 23. The Global Research & Industry Alliance, led by the Ministry of Science and Technology, will feature 14 schools from the Alliance participating in the exhibition.
Picture / Provided by National Taiwan Ocean University

(News and pictures authorized by Commercial Times)
The 2020 Bio Asia-Taiwan Exhibition will officially start on July 23. With the novel coronavirus pandemic raging this year, the organizer names the event "Finding Solutions in Crisis" and focuses on five major topics for the global fight against the pandemic. The Global Research & Industry Alliance, led by the Ministry of Science and Technology, will feature 14 schools from the Alliance participating in the exhibition. The Alliance focuses on the forward-looking fields and hopes to drive NT$4 billion of industry research and development funds into academia to cultivate talents for the industry. 
 
With the fight against the coronavirus pandemic becoming a trend, many schools in the Alliance have come up with their own anti-virus applications. For example, National Chung Hsing University developed a broad-spectrum anti-coronavirus drug P3 which enables the ends of individual nucleocapsid proteins to overlap to lose the pathogenic ability, with little side effects. It has recently been confirmed that P3 has a broad-spectrum inhibitory effect on a variety of coronaviruses including COVID-19, and can alleviate the clinical symptoms of animals affected by coronaviruses. 
 
The results of the development have been selected to be on the cover of the March issue of the Journal of Medicinal Chemistry. The study has been downloaded more than 7,000 times and is highly valued by academia and the industry.
 
The other drug from National Chung Hsing University is NucleiChemR which combines two types of compounds with different functions to form a new dosage form. Experiments have found that the drug is effective at low concentrations, especially for cancers with inactivated DNA mismatch repair (MMR) function. It is hoped that the findings may help the development of a new type of cancer treatment strategy. 
 
National Taiwan Ocean University hopes to find solutions from algae, such as using algae extracts to treat and prevent the infection of the Influenza A virus. Taiwan is surrounded by the ocean which provides the island with rich algae ecology. The mass production technologies of National Taiwan Ocean University for algae functional extracts help the school achieve effective and safe content of ingredients in a more convenient and faster manner, offering more comprehensive effects on fighting viruses and immune regulation.
 
In addition, National Taiwan Ocean University has achieved a cross-domain technological breakthrough in the use of food-grade raw materials to make food-grade antibacterial materials that can inhibit harmful bacteria and even viruses and be widely used in various food utensils.
 
Besides the research and development efforts in pandemic control, National Taiwan Ocean University will demonstrate high-value quality aquatic seedlings and red algae phycobiliprotein product development technologies based on the Lipoplex oral delivery platform to connect the aquafarming-related industries and establish new collaborative opportunities in sustainability and between countries with rich marine resources.

本網站使用您的Cookie於優化網站及您的瀏覽經驗。繼續瀏覽網站即表示您同意本公司隱私權政策,您可至隱私權政策了解詳細資訊。